ArticleHaematologica2018

Development of angiotensin II (1-7) analog as an oral therapeutic for the treatment of chemotherapy-induced myelosuppression.

Kevin Gaffney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.